Logo image
Autonomous Artificial Intelligence in Diabetic Retinopathy: From Algorithm to Clinical Application
Journal article   Open access   Peer reviewed

Autonomous Artificial Intelligence in Diabetic Retinopathy: From Algorithm to Clinical Application

Roomasa Channa, Risa Wolf and Michael D Abramoff
Journal of diabetes science and technology, Vol.15(3), pp.695-698
2021
DOI: 10.1177/1932296820909900
PMID: 32126819
url
https://doi.org/10.1177/1932296820909900View
Published (Version of record) Open Access

Abstract

Artificial intelligence (AI)-based algorithms are rapidly entering the health care field and have the potential to improve patient care. Our article focuses on the use of autonomous AI algorithms (ie, algorithms that can make clinical decisions without human oversight) in diagnostic imaging. In this article, we have used the example of diabetic retinopathy screening to highlight some important aspects to be considered by developers, policymakers, and end users when bringing autonomous AI algorithms into clinical practice. We have divided these aspects into (1) following the principles of safety, efficacy, and equity in all phases of development and implementation of the algorithm; (2) regulatory processes involving medical records, medical liability, and patient privacy; (3) cost and billing; and (4) the role of health care providers.

Details

Metrics

Logo image